Oct. 3, 2023

Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry

Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry
Spotify podcast player badge
Apple Podcasts podcast player badge
Pandora podcast player badge
RSS Feed podcast player badge
Spotify podcast player iconApple Podcasts podcast player iconPandora podcast player iconRSS Feed podcast player icon

Tune into Episode #2 of the LifeSci Search podcast with Andy Cronin (President & Co-Founder) and Ayesha Price (Sr. Director, Executive Search) as they host Iris Grossman (Chief Therapeutics Officer, Eleven Therapeutics) and Shahram Ebadollahi (Operating Partner, ARCHIMED & Former Chief Data Officer, Novartis) on the topic of AI and ML tools in Drug R&D. We get insights on how the tech is being leveraged in biotech and pharma along the R&D process, overall impact so far, thinking around AI and ML among leadership teams & boards, and perspectives on the competition for AI and ML talent within Life Sciences industry.